Volume 179 - Issue 2
Bowel wall "thumbprinting" in pseudomembranous colitis
Authors: Moishe Liberman, Chris Labos and Jeff Wiseman
Med J Aust 2003; 179 (2): 107. || doi: 10.5694/j.1326-5377.2003.tb05448.x
Published online: 21 July 2003
Published online: 21 July 2003
A 39-year-old woman with AIDS (CD4 count, 30 cells/mL) had a 4-day history of nausea, vomiting and profuse watery diarrhoea. The patient was afebrile and had a distended abdomen with diffuse guarding without rebound tenderness. Abdominal x-rays (Box 1) and computed tomography scans (Box 2) were performed. The white blood cell count was within normal limits and stool cultures were negative. Colonoscopy revealed yellow plaques throughout the colon. The patient improved clinically after taking oral metronidazole.
Bowel wall "thumbprinting" (the appearance of "thumbprint"-shaped projections) is a radiological sign of thickening of the colonic wall. It occurs secondary to submucosal haemorrhage and oedema from capillary leakage.1 It can result from any process that leads to oedema of the bowel wall, including pseudomembranous colitis (as shown here), ischaemic colitis, non-infective inflammatory bowel disease, other infective bowel diseases, submucosal/intramural haemorrhage and other conditions.2 The mucosal damage and inflammation seen in pseudomembranous colitis are caused by Clostridium difficile toxin.3
References
- Grainger RG, Allison D, Adam A, et al (editors). Grainger and Allison's diagnostic radiology: a textbook of medical imaging. 4th ed. New York: Churchill Livingstone, 2001: 1132.
- Gore RM, Levine MS. Textbook of gastrointestinal radiology. 2nd ed. Philadelphia: WB Saunders, 2000: 1163. i1082739
- Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262. i1082741
Australian Pathways for Specialist Pain Management and Early Palliative Care for People With Pancreatic Cancer: Developed Using a Community Consensus Approach
Jennifer Philip, Melanie R. Lovell, Kylee Bellingham, Gail Garvey, Gregory B. Crawford, Nicole M. Rankin, Kara Burns, Isabel Young, Vivienne Milch, Dorothy Keefe, Katrina Anderson, James Lawson, Meinir Krishnasamy
Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study
Vikas Bhasker, Jessica R Fong, Paul J Clark, Gunter F Hartel, Richard Skoien, James O’Beirne, Elizabeth E Powell, Patricia C Valery
Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations
Jacob George, Nicole L Allard, Stuart K Roberts, Leon A Adams, Jane Davies, Behzad Hajarizadeh, Jennifer H MacLachlan, Suzanne E Mahady, Rosalie Altus, Catherine Brown, David C Fry, Belinda Greenwood‐Smith, Natali Smud, Patricia C Valery, Nafisa Yussf, Kate Broun, Denise Campbell, Karen Canfell, Chelsea Carle Harrison, Victoria Freeman, Paul Grogan, Catherine Holliday, Suzanne Hughes, Anna Kelly, Cathelijne Kemenade, Claire Latumahina, Amanda McAtamney, Megan Varlow, Joachim Worthington, Susan Yuill, Eleonora Feletto
Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
Leon A Adams, William W Kemp, Kate R Muller, Elizabeth E Powell, Stuart K Roberts, Luis Calzadilla Bertot, Stephanie Best, Gary Deed, Jon D Emery, Samantha L Hocking, Graham R Jones, John S Lubel, Sinead Sheils, Stephen M Twigg, Gerald F Watts, Jacob George
Treatment outcomes for people with hepatitis C referred to tertiary care in Victoria, 2021–22: a retrospective observational study
Elly Layton, Nicole Matthews, Brendan Quinn, Nasra Higgins, Gabrielle Lindeman, Mielle Abbott, Jennifer MacLachlan, Elizabeth Birbilis, Margaret E Hellard, Joseph Doyle, Benjamin C Cowie, Mark Stoové
Participation in the National Bowel Cancer Screening Program by people with severe mental illness, Australia, 2006–2019: a national data linkage study
Oyedeji Ayonrinde, Sara Mohamed, Jenna Nensi